Clinical Trial Update: A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating 18F-AlF-NOTA-Neurotensin PET/CT for imaging prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN